Title : Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.

Pub. Date : 2014 Sep

PMID : 24628035






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. TA-8995 cholesteryl ester transfer protein Homo sapiens
2 Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. TA-8995 cholesteryl ester transfer protein Homo sapiens
3 AIMS: Two double-blind, randomized studies were conducted to assess the tolerability, pharmacokinetics and pharmacodynamics of oral TA-8995, a new cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. TA-8995 cholesteryl ester transfer protein Homo sapiens
4 AIMS: Two double-blind, randomized studies were conducted to assess the tolerability, pharmacokinetics and pharmacodynamics of oral TA-8995, a new cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. TA-8995 cholesteryl ester transfer protein Homo sapiens
5 CONCLUSIONS: TA-8995 is a potent CETP inhibitor and warrants further investigation. TA-8995 cholesteryl ester transfer protein Homo sapiens